Cefuroxime
General
- Type: 2nd generation cephalosporin
- Dosage Forms: PO
- Common Trade Names: Ceftin
Adult Dosing
Mild-Moderate Bacterial infections
- 250-500 mg PO bid x5-10 days
Steptococcal Pharyngitis/Tonsillitis
- 250 mg PO bid x10 days
Acute Maxillary Sinusitis
- 250 mg PO bid x10 days; Info: not recommended per IDSA guidelines
Uncomplicated Gonococcal Infections
- 1000 mg PO x1; Info: for infections of cervix, urethra, rectum; dual tx for chlamydial co-infection recommended
Early Lyme Disease
- 500 mg PO bid x20 days
Renal Dosing
- no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement
Hepatic Dosing
- not defined
Pediatric Dosing
Mild-Moderate Bacterial Infections
- 3 mo-12 yo: Dose: 30 mg/kg/day susp PO divided q12h x10 days; Max: 1000 mg/day; Alt: 250 mg tab PO bid x10 days; Info: give susp w/ food
- >13 yo: Dose: 250-500 mg tab PO bid x5-10 days; Info: dose, duration varies by infection type, severity
Acute Otitis Media
- 2 mo-5 yo Dose: 30 mg/kg/day susp PO divided q12h x10 days; Max: 1000 mg/day; Alt: 250 mg tab PO bid x10 days; Info: give susp w/ food
- 6-12 yo: Dose: 30 mg/kg/day susp PO divided q12h x5-10 days; Max: 1000 mg/day; Alt: 250 mg tab PO bid x5-10 days; Info: give susp w/ food
Acute Maxillary Sinusitis
- 3 mo-12 yo: Dose: 30 mg/kg/day susp PO divided q12h x10 days; Max: 1000 mg/day; Alt: 250 mg tab PO bid x10 days; Info: not recommended per IDSA guidelines; give susp w/ food
- >13 yo: Dose: 250 mg tab PO bid x10 days; Info: not recommended per IDSA guidelines
Streptococcal Pharyngitis/Tonsillitis
- 3 mo-12 yo: Dose: 20 mg/kg/day susp PO divided q12h x10 days; Max: 500 mg/day; Info: give w/ food
- >13 yo: Dose: 250 mg tab PO bid x10 days
Uncomplicated Gonococcal Infections
- adolescents: Dose: 1000 mg tab PO x1; Info: for infections of cervix, urethra, rectum; dual tx for chlamydial co-infection recommended
Early Lyme Disease
- >13 yo: Dose: 500 mg tab PO bid x20 days
Renal Dosing
- 3 mo-12 yo: CrCl <10: 15 mg/kg susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement
- >13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement
Hepatic Dosing
- not defined
Special Populations
- Pregnancy: B
- Lactation: Probably Safe
- Renal Dosing
- Adult: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement
- Pediatric
- Hepatic Dosing
- Adult: No defined
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
